Drug recall · January 12, 2022
Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets recall
Why: Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets, 24HR, 180mg Antihistamine, packaged as a) 30 count bottle, NDC 11822-0571-2 UPC 0 11822 99908 3; b) 150 count bottle, NDC 11822-0571-5 UPC 0 11822 85411 5; Made in the Czech Republic, Distributed by Rite Aid 30 Hunter Lane Camp Hill PA 17011
- Lots / codes
Lot # a) 1BR0462, Exp 10/31/2022 b) 0GR0528, Exp 3/31/2022; 0KR0473, Exp 4/30/2022; 0LR0369, Exp 6/30/2022
- Quantity
- 44,688 containers
- Company
- Perrigo Company PLC, Allegan, MI
- Distribution
- Nationwide in the USA
- Initiated
- July 27, 2021 · Voluntary: Firm initiated
- Classified
- January 5, 2022
- Reported
- January 12, 2022
- Ended
- November 8, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fexofenadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.